The life expectancy for someone with aortic stenosis depends on a variety of factors. Older age, severe calcium buildup of the valve leaflets, high blood pressure, obesity, smoking, high ...

ACURATE neo2 TAVI achieves high success in severe bicuspid aortic stenosis, demonstrating strong 30-day safety and efficacy.

In the United States about 10% of aortic stenosis is caused by rheumatic disease and the remainder by calcification of a unicuspid, bicuspid, or normal trileaflet valve. [11–14] Calcific aortic ...

Background Aortic stenosis is a degenerative condition with high mortality in its severe stages and no preventive treatment.

Aortic stenosis, affecting nine million people globally, is often unnoticed as symptoms are mistaken for aging. This heart condition, common in elderly, restricts blood flow due to valve narrowing ...

CHANDIGARH: 87 years old, Tara Chand (name changed), resident of Panchkula, had undergone a non-surgical procedure for aortic ...

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...

The Medicare data contradict results from the TCW randomized trial but better represent real-world practice, say authors.

New Delhi: Global medical device maker Abbott has introduced the Navitor Vision in India, a state-of-the-art valve technology for treating symptomatic severe aortic stenosis in patients who face ...

Myval THV matches SAPIEN and Evolut THVs in 30-day outcomes, supporting its role in severe aortic stenosis treatment.